T78079 |
NF546 hydrate
|
|
98%
|
|
NF546 (hydrate), a selective non-nucleotide P2Y11 agonist, exhibits a pEC50 value of 6.27 and induces interleukin-8 secretion from human monocyte-derived dendrit...
|
T78080 |
PSB-1114 triethylamine
|
|
98%
|
|
PSB-1114 triethylamine is a potent, enzymatically stable, P2Y2 receptor agonist with a 134 nM EC50, exhibiting greater than 50-fold selectivity over P2Y4 (EC50 o...
|
T78583 |
Uridine 5'-diphosphate
|
58-98-0
|
98%
|
|
Uridine 5'-diphosphate acts as a P2Y6 receptor agonist, exhibiting an EC50 value of 0.013 μM for the human P2Y6 receptor [1].
|
T79196 |
4-Thiouridine 5′-triphosphate tetralithium
|
20188-72-1
|
98%
|
|
4-Thiouridine 5′-triphosphate tetralithium (4-Thio-UTP), a potent P2Y2 and P2Y4 receptor agonist, exhibits EC50 values of 35 nM for hP2Y2 and 350 nM for hP2Y4. I...
|
T79197 |
4-Thiouridine 5′-triphosphate tetrasodium
|
|
98%
|
|
4-Thiouridine 5′-triphosphate (4-Thio-UTP) tetrasodium functions as a potent agonist at P2Y 2 and P2Y 4 receptors, with half-maximal effective concentrations (EC...
|
T5501 |
Clopidogrel thiolactone
|
1147350-75-1
|
98%
|
|
Clopidogrel thiolactone (2-oxoclopidogrel) is a potent P2Y12 receptor inhibitor and a potent antiplatelet aggregation compound.Clopidogrel thiolactone is the act...
|
T63534 |
PPTN hydrochloride
|
1992047-65-0
|
99.94%
|
|
PPTN hydrochloride is a potent, high-affinity, competitive, highly selective P2Y14 receptor antagonist (KB: 434 pM), but no agonist or antagonist activity at P2Y...
|
T4743 |
Uridine 5′-diphosphoglucose disodium salt
|
28053-08-9
|
99.83%
|
|
Uridine 5′-diphosphoglucose disodium salt (UDP-Glucose sodium salt) is an endogenous nucleotide sugar involved in glycosyltransferase reactions in Metabolism. It...
|
T6952 |
Prasugrel Hydrochloride
|
389574-19-0
|
99.79%
|
|
Prasugrel Hydrochloride (LY 640315 Hydrochloride) is a piperazine derivative and pletelet aggregation inhibitor that is used to prevent thrombosis in patients wi...
|
T7423 |
Diquafosol tetrasodium
|
211427-08-6
|
99.68%
|
|
Diquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium (INS365) improves tear film ...
|
T0182L2 |
(±) Clopidogrel hydrogen sulfate
|
135046-48-9
|
99.62%
|
|
(±) Clopidogrel hydrogen sulfate (Iscover) , an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in...
|
T0182L |
Clopidogrel hydrogen sulfate
|
120202-66-6
|
99.57%
|
|
Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) , a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets ...
|
T28463 |
PSB-16133 sodium
|
2089035-40-3
|
99.36%
|
|
PSB-16133 sodium is a selective P2Y purine receptor variant antagonist with an IC of 233 nM.
|
T12164 |
N6-(4-Hydroxybenzyl)adenosine
|
110505-75-4
|
99.18%
|
|
N6-(4-Hydroxybenzyl)adenosine (Para-topolin riboside) is a platelet aggregation inhibitor.
|
T5036 |
Cangrelor tetrasodium
|
163706-36-3
|
99.15%
|
|
Cangrelor tetrasodium is a reversible and selective antagonist of platelet P2Y12, with prompt and potent antiplatelet effects.
|
T21059 |
Ticagrelor metabolite M5
|
1251765-07-7
|
99.09%
|
|
Ticagrelor metabolite M5 (T437700) is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor. Compared to Clopidogrel, Ticagrelor has...
|
T23164 |
PIT
|
56583-49-4
|
99.01%
|
|
PIT (2,2'-Pyridylisatogen tosylate) is a specific and non-competitive antagonist of the Purinergic receptor P2Y1 with an IC50 of 0.14 μM for human P2Y1. PIT does...
|
T0230 |
Prasugrel
|
150322-43-3
|
98.62%
|
|
Prasugrel (CS-747) is a piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNS...
|
T4706 |
Uridine-5'-diphosphate disodium salt
|
27821-45-0
|
98.6%
|
|
Uridine-5'-diphosphate disodium salt (UDP disodium salt) is a specific agonist of the P2Y6 receptors (EC50 = 13 nM for human P2Y6), stimulating the production of...
|
T0182 |
Clopidogrel
|
113665-84-2
|
98.47%
|
|
Clopidogrel (SR-25990C), a P2Y12 receptor antagonist, decreases platelet aggregation.
|